Developed with guidance from Dr. Michael Fredericson, co-director of the Stanford Center on Longevity, the formula goes beyond standard monohydrate. It integrates micronized creatine with HMB to minimize exercise-related muscle damage and pomegranate polyphenols, which serve as precursors to urolithin A for mitochondrial renewal. According to the company, this combination addresses the biological foundations of aging by supporting cellular energy production alongside structural muscle maintenance.

Elysium CEO Eric Marcotulli noted that the product reflects a broader shift in wellness, where muscle health is increasingly viewed as a primary indicator of independence and longevity. While creatine has historically been marketed to gym-goers, this iteration is specifically calibrated for the physiological needs of aging men and women. The supplement is available starting June 15, 2026, through the company’s official website, marking a move to translate advanced aging research into accessible, daily nutritional interventions.